Establishing doxorubicin resistant HCC1806 triple negative breast cancer cell lines result in the differential expression of let7a and miR34a

Checo J Rorie; Malcolm Moses; Mohammed Musa; Sherette Godfrey

Establishing doxorubicin resistant HCC1806 triple negative breast cancer cell lines result in the differential expression of let7a and miR34a

Checo J Rorie
, Malcolm Moses
, Mohammed Musa
, Sherette Godfrey

Biology

Research output: Chapter in Book/Report/Conference proceeding › Conference contribution

Original language	English
Title of host publication	Unknown book
State	Accepted/In press - 2017

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@inproceedings{9b3a5d4b3b574d58a9acfaa578f52408,

title = "Establishing doxorubicin resistant HCC1806 triple negative breast cancer cell lines result in the differential expression of let7a and miR34a",

author = "Rorie, \{Checo J\} and Malcolm Moses and Mohammed Musa and Sherette Godfrey",

year = "2017",

language = "English",

booktitle = "Unknown book",

}